CONDITION
Immune-Mediated Polyarthritis
Immune-mediated polyarthritis describes a pattern in which the body's immune system generates inflammation inside multiple joints. The inflammation is not caused by infection inside the joint or by injury, but by immune activity that has, for reasons often unclear, begun to target the joint tissues themselves. The result is pain, stiffness, and swelling that can appear quite suddenly or build over days. Owners often notice reluctance to move, a stiff or shifting gait, or a dog who seems uncomfortable when rising or navigating stairs. The pattern can affect several joints at once, and the signs may come and go or persist. In some cases, there is a recognisable trigger (an infection elsewhere, a drug, or another immune condition), but in many, the cause remains uncertain. This page explores what these signs can indicate, what may be happening beneath the surface, how the condition is investigated through examination and joint fluid analysis, and the range of approaches used to manage immune-driven joint inflammation over time.
Why this matters now
Immune-mediated polyarthritis can develop at any age, though different types may have age predispositions. Some forms appear more common in young to middle-aged dogs. Nova Scotia Duck Tolling Retrievers have a documented genetic association with an immune-mediated rheumatic disease that causes a non-erosive arthritis. Breed-associated forms are also described in Akitas, Chinese Shar-Pei and spaniel breeds, and Boxers, Weimaraners and Bernese Mountain Dogs are among the breeds reported. The condition often develops over days to weeks, though onset can sometimes be more acute.
The condition typically causes joint pain and stiffness that may shift between joints or affect multiple joints simultaneously. Early signs can be subtle, with dogs appearing stiff or reluctant to exercise without obvious lameness. As inflammation persists, joint swelling may become apparent. Without treatment, ongoing immune attack can damage joint structures. The course often fluctuates, with periods of worsening and improvement. Fever, lethargy and reduced appetite are common alongside the joint signs.
Signals & patterns
Early signals
Generalised stiffness, especially after rest
Difficulty rising and stiff movement that may improve with gentle activity but differs from typical age-related stiffness.
Reluctance to walk or exercise
Decreased enthusiasm for activities, though no single limb may appear obviously lame.
Shifting leg lameness
Lameness that seems to move between legs or affects different limbs on different occasions.
Reduced appetite and lethargy
General unwellness often accompanies the joint signs, suggesting systemic involvement.
Fever
A raised temperature is common at diagnosis: in a 2025 study of dogs with idiopathic IMPA, about 60% had a temperature of 39.5°C or more.
Later signals
Visible joint swelling
Affected joints may appear enlarged or feel warm compared to normal.
Pain on joint manipulation
Clear discomfort when affected joints are flexed or extended during examination.
Reluctance to bear weight
More obvious lameness or reluctance to put weight on affected limbs.
Click to read about the biological mechanisms
How this is usually investigated
Diagnosis requires demonstrating joint inflammation whilst excluding infectious causes and identifying any underlying conditions. Joint fluid analysis is central to diagnosis.
Joint fluid analysis (arthrocentesis)
Blood tests
Radiographs of affected joints
Bacterial culture of joint fluid
Testing for underlying conditions
Options & trade-offs
Treatment aims to suppress the abnormal immune response whilst addressing any underlying cause. Long-term management is often necessary.
Immunosuppressive doses of corticosteroids
Higher doses of steroids to dampen the immune attack on joints.
Trade-offs: Usually effective initially. Associated with predictable side effects including increased thirst, hunger, and urination. Long-term use requires monitoring for complications.
Steroid-sparing immunosuppressive drugs
Medications such as azathioprine, ciclosporin, or mycophenolate used to reduce steroid requirements. None is authorised in the UK for IMPA in dogs: ciclosporin is authorised for dogs only for atopic dermatitis, and azathioprine and mycophenolate are human medicines, so all three are used under the veterinary medicines cascade.
Trade-offs: May allow steroid dose reduction. Each has specific monitoring requirements. Some take weeks to reach full effect: the effects of azathioprine can take 3 to 6 weeks to be seen.
Treatment of underlying conditions
Addressing any identified triggers such as infections or other diseases.
Trade-offs: Central to secondary IMPA. Resolution of the underlying cause may allow immunosuppressive treatment to be reduced or stopped.
Pain management
Analgesic medications to provide comfort whilst anti-inflammatory treatment takes effect.
Trade-offs: Improves quality of life during flares. Non-steroidal anti-inflammatory drugs (NSAIDs) are not given together with corticosteroids, because the combination raises the risk of stomach and gut ulceration, so other pain relief is chosen while steroids are in use.
Gradual medication reduction
Slowly tapering immunosuppressive treatment once the condition is controlled.
Trade-offs: Aims to find the minimum effective dose or achieve drug-free remission. Relapse can occur, requiring treatment adjustment.
Common misconceptions
"IMPA is the same as osteoarthritis"
These are fundamentally different conditions. IMPA results from immune attack on joints, whilst osteoarthritis develops from wear and tear. They require different treatments.
"Once signs improve, treatment can simply stop"
IMPA treatment is reduced gradually, step by step, once signs are controlled, rather than stopped when the dog looks well. Relapse is common even so: in a 2025 study of dogs with idiopathic IMPA, the estimated relapse rate was 61% at 12 months.
"Dogs with IMPA cannot have a good quality of life"
With appropriate management, many dogs with IMPA can return to comfortable, active lives. The condition is controllable in most cases, though long-term medication may be needed.
Related conditions
Septic Arthritis
Septic arthritis can present with similar signs of joint pain, swelling, and reluctance to move, but is driven by infection rather than immune-mediated inflammation. Distinguishing between the two often requires analysis of joint fluid, as the treatment approach and prognosis differ considerably.
The page on this condition is being checked again and is offline for now.
Glomerulonephritis
Glomerulonephritis can occur alongside immune-mediated polyarthritis when immune complexes circulating in the blood settle in both joint tissues and the kidney's filtering units. In some cases, the same underlying immune activity affects multiple organ systems at once.
Lyme Nephritis
Lyme nephritis is a serious kidney disease (a protein-losing glomerulonephritis) linked to Borrelia burgdorferi infection. The same infection is one of the infectious triggers of joint inflammation in dogs, but the two problems usually occur separately: fewer than 30% of dogs with Lyme nephritis have a history of Lyme arthritis.
Steroid-Responsive Meningitis-Arteritis (SRMA)
SRMA is another immune-mediated disease, seen mostly in dogs under two years of age, in which inflammation affects the membranes and blood vessels around the brain and spinal cord. It causes pain, a stiff gait, reluctance to move the neck and often fever, and the joints can be inflamed at the same time, so the two conditions can look alike and can occur together.
Discospondylitis
Discospondylitis, an infection of the vertebrae and the discs between them, can look similar because it causes stiffness and reluctance to move. Spinal pain is the most consistent finding, and fever, dullness and weight loss are less common, whereas IMPA centres on painful, often swollen limb joints.
Noting which joints seem affected and whether this changes over time can help characterise the condition. Observing when stiffness is most pronounced, such as after rest versus after activity, provides useful information. Documenting any associated signs such as reduced appetite or apparent fever helps build a complete picture for veterinary evaluation.
Last reviewed: 9 October 2026 · Dr Alastair Greenway MRCVS